ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 176 filers reported holding ARGENX SE in Q2 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,789 | +19.1% | 85 | -5.6% | 0.01% | +16.7% |
| Q2 2023 | $35,076 | +2.3% | 90 | -2.2% | 0.01% | 0.0% |
| Q1 2023 | $34,277 | -12.2% | 92 | -10.7% | 0.01% | -14.3% |
| Q4 2022 | $39,019 | +25.9% | 103 | +15.7% | 0.01% | 0.0% |
| Q3 2022 | $31,000 | 0.0% | 89 | +7.2% | 0.01% | +16.7% |
| Q2 2022 | $31,000 | +106.7% | 83 | +69.4% | 0.01% | +100.0% |
| Q1 2022 | $15,000 | -21.1% | 49 | -10.9% | 0.00% | 0.0% |
| Q4 2021 | $19,000 | +5.6% | 55 | -5.2% | 0.00% | -25.0% |
| Q3 2021 | $18,000 | 0.0% | 58 | -1.7% | 0.00% | 0.0% |
| Q2 2021 | $18,000 | +12.5% | 59 | +3.5% | 0.00% | +33.3% |
| Q1 2021 | $16,000 | -42.9% | 57 | -41.8% | 0.00% | 0.0% |
| Q4 2020 | $28,000 | – | 98 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |